Preclinical evidence for combining the 5-HT2C receptor agonist lorcaserin and varenicline as a treatment for nicotine dependence

Addiction Biology
Paul J FletcherGuy A Higgins

Abstract

Varenicline, a nicotinic acetylcholine receptor partial agonist, is used to treat nicotine dependence. Lorcaserin, a 5-HT2C receptor agonist has been approved in some countries to treat obesity. Based on preclinical and preliminary clinical evidence, lorcaserin may have potential to treat nicotine dependence. These experiments examined in rats the effects of combining varenicline (0.5 or 1 mg/kg) and lorcaserin (0.3, 0.6 and 1 mg/kg) on nicotine self-administration, reinstatement of nicotine seeking, responding for food and impulsive action. Both drugs alone reduced nicotine self-administration. Combining varenicline and 0.6 mg/kg lorcaserin reduced responding to a greater extent than either drug alone. In a relapse model, extinguished nicotine seeking was reinstated by a priming injection of nicotine and nicotine-associated cues. Reinstatement was reduced by varenicline (1 mg/kg) and by lorcaserin (0.3 mg/kg). Combining lorcaserin (0.3 mg/kg) with varenicline (0.5 or 1 mg/kg) reduced reinstatement to a greater degree than either drug alone. Both drugs had minimal effects on responding for food, alone or in combination. In the five-choice serial reaction time test, varenicline (0.5 or 1 mg/kg) increased impulsivity, measured as...Continue Reading

References

Aug 1, 1996·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J L MoreauJ Wichmann
Sep 2, 1998·Psychopharmacology·N R Mirza, I P Stolerman
Jan 15, 2004·The Journal of Pharmacology and Experimental Therapeutics·Massimo PierucciEnnio Esposito
Jun 13, 2006·Psychopharmacology·Marcel M van GaalenLouk J M J Vanderschuren
Jul 6, 2006·JAMA : the Journal of the American Medical Association·David GonzalesUNKNOWN Varenicline Phase 3 Study Group
Jul 6, 2006·JAMA : the Journal of the American Medical Association·Serena TonstadUNKNOWN Varenicline Phase 3 Study Group
Feb 14, 2007·Psychopharmacology·Sharon Rosenzweig-LipsonKaren L Marquis
Jun 19, 2007·Trends in Pharmacological Sciences·Hans RollemaKathryn E Williams
Jul 10, 2007·European Journal of Pharmacology·Magdalena ZaniewskaMalgorzata Filip
Jul 27, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Paul J FletcherGuy A Higgins
Sep 22, 2007·Biological Psychiatry·Leontien DiergaardeTaco J De Vries
Jul 8, 2008·Psychopharmacology·Kenneth A PerkinsAnnette S Wilson
Sep 18, 2008·Synapse·Magdalena ZaniewskaMałgorzata Filip
Dec 6, 2008·Obesity·Steven R SmithUNKNOWN APD356-004 Study Group
Apr 14, 2009·Pharmacology & Therapeutics·Jack E HenningfieldEllen R Gritz
Feb 16, 2010·Neuropharmacology·Magdalena ZaniewskaMałgorzata Filip
Jan 25, 2011·Trends in Pharmacological Sciences·Riccardo Polosa, Neal L Benowitz
May 5, 2011·Archives of Suicide Research : Official Journal of the International Academy for Suicide Research·Yari Gvion, Alan Apter
Jun 4, 2011·The Journal of Pharmacology and Experimental Therapeutics·Edward D LevinJed E Rose
Nov 11, 2011·PloS One·Thomas J MooreSonal Singh
Dec 23, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Guy A HigginsPaul J Fletcher
Jan 12, 2012·JAMA : the Journal of the American Medical Association·Bridget M Kuehn
Jul 12, 2012·BMJ : British Medical Journal·Henri-Jean AubinPaul Aveyard
Dec 7, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Nancy K MelloF Ivy Carroll
Apr 15, 2015·ACS Chemical Neuroscience·Guy A Higgins, Paul J Fletcher
Mar 5, 2016·Nature Reviews. Endocrinology·Kindred K HarrisTheodore C Friedman
Apr 27, 2016·Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco·Muhannad MalasRoberta Ferrence
May 10, 2016·The Cochrane Database of Systematic Reviews·Kate CahillTim Lancaster
Nov 8, 2016·BMC Pharmacology & Toxicology·Shamia L FaisonJia Bei Wang
Oct 19, 2017·Drug and Alcohol Dependence·David S JacobsStephen J Kohut

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved